Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease
- PMID: 20595454
- PMCID: PMC3035488
- DOI: 10.1378/chest.10-0693
Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease
Abstract
Objective: In this study, we aimed to determine the validity and reliability of the Dyspnea-12 questionnaire (D-12) for the assessment of breathlessness in patients with interstitial lung disease (ILD).
Methods: A total of 101 patients with ILD completed the D-12 (scale range, 0-36, with a high score indicating worse dyspnea), Medical Research Council (MRC) dyspnea scale, St. George Respiratory Questionnaire (SGRQ), and Hospital Anxiety and Depression Scale (HADS) at baseline, and 84 patients completed the D-12 and a global health transition score at follow-up 2 weeks later. D-12 psychometric properties, including floor and ceiling effects, internal consistency, test-retest reliability, and construct validity were examined.
Results: The D-12 showed good internal consistency (Cronbach α, 0.93) and repeatability (intraclass correlation coefficient, 0.94). Its scores were significantly associated with MRC grade (r = 0.59; P < .001), SGRQ (symptoms, r = 0.57; activities, r = 0.78; impacts, r = 0.75; total, r = 0.79; P < .001). Factor analysis confirmed the previously determined structure of the D-12 in this patient group.
Conclusion: In patients with ILD, the D-12, a patient-reported measure of dyspnea severity that requires no reference to activity, is a reliable and valid instrument. It is short, simple to complete, and easy to score.
Figures
Similar articles
-
Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.Respirology. 2012 Apr;17(3):506-12. doi: 10.1111/j.1440-1843.2012.02131.x. Respirology. 2012. PMID: 22257381
-
Assessment of Breathlessness in Lung Cancer: Psychometric Properties of the Dyspnea-12 Questionnaire.J Pain Symptom Manage. 2017 Feb;53(2):208-215. doi: 10.1016/j.jpainsymman.2016.08.009. Epub 2016 Oct 5. J Pain Symptom Manage. 2017. PMID: 27720789
-
Validation of a Dyspnea Visual Analog Scale in Fibrotic Interstitial Lung Disease.Ann Am Thorac Soc. 2024 Jul;21(7):1007-1014. doi: 10.1513/AnnalsATS.202307-658OC. Ann Am Thorac Soc. 2024. PMID: 38315632
-
Pathophysiological mechanisms of exertional breathlessness in chronic obstructive pulmonary disease and interstitial lung disease.Curr Opin Support Palliat Care. 2018 Sep;12(3):237-245. doi: 10.1097/SPC.0000000000000377. Curr Opin Support Palliat Care. 2018. PMID: 30074922 Review.
-
Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review.BMC Pulm Med. 2018 May 22;18(1):78. doi: 10.1186/s12890-018-0651-3. BMC Pulm Med. 2018. PMID: 29788938 Free PMC article.
Cited by
-
Reliability and validity of an arabic version of the dyspnea-12 questionnaire for Saudi nationals with chronic obstructive pulmonary disease.Ann Thorac Med. 2015 Apr-Jun;10(2):112-7. doi: 10.4103/1817-1737.150730. Ann Thorac Med. 2015. PMID: 25829962 Free PMC article.
-
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?Eur Respir Rev. 2021 May 25;30(160):210026. doi: 10.1183/16000617.0026-2021. Print 2021 Jun 30. Eur Respir Rev. 2021. PMID: 34039675 Free PMC article. Review.
-
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52. doi: 10.1164/rccm.201111-2042ST. Am J Respir Crit Care Med. 2012. PMID: 22336677 Free PMC article.
-
Reliability, Validity, and Responsiveness of the DEG, a Three-Item Dyspnea Measure.J Gen Intern Med. 2022 Aug;37(10):2541-2547. doi: 10.1007/s11606-021-07307-1. Epub 2022 Jan 3. J Gen Intern Med. 2022. PMID: 34981344 Free PMC article. Clinical Trial.
-
A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease.Sci Rep. 2021 Mar 25;11(1):6874. doi: 10.1038/s41598-021-86326-8. Sci Rep. 2021. PMID: 33767311 Free PMC article. Clinical Trial.
References
-
- Wells AU, Hirani N. The British Thoracic Society ILD Guidelines. Thorax. 2008;63(suppl 5):v1–v51. - PubMed
-
- Martinez TY, Pereira CAC, dos Santos ML, Ciconelli RM, Guimarães SM, Martinez JA. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest. 2000;117(6):1627–1632. - PubMed
-
- Swigris JJ, Gould MK, Wilson SR. Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest. 2005;127(1):284–294. - PubMed
-
- Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85(6):751–758. - PubMed